Investing.com – The futures of US actions dropped slightly on Thursday night while investors evaluated the results of Apple and Amazon that reflect tariff concerns, while Wall Street recorded profits in the regular session, driven by the solid results of Microsoft and goal of the previous day.
S&P 500 futures dropped 0.2% to 5,612.25 points, while Nasdaq 100 futures fell 0.4% to 19,798.75 points at 20:02 (00:02 GMT). Dow Jones futures dropped 0.1% to 40,838.0 points.
The actions of the iPhone manufacturer, Apple (Nasdaq: AAPL), fell 3.8% in the extended operations on Thursday after the company said it foresees about 900 million dollars in costs for the next quarter due to tariffs.
Apple presented results of the second fiscal quarter that overcome Wall Street estimates thanks to better iPhone sales than expected, but tariff concerns decreased optimism.
Meanwhile, Amazon (Nasdaq: AMZN) reported a weaker forecast for current quarter and disappointing growth in its key cloud computing segment.
Amazon predicted an operational income for the second quarter of between 13,000 million and 17,500 million dollars, below the estimates of 17,820 million dollars.
Amazon shares fell almost 3% after closing.
In the regular session on Thursday, the Dow Jones Industrial Avenge closed a 0.2%higher, while the S&P 500 won 0.6%, and the Nasdaq Composite rose 1.5%.
Meta Platforms Inc (Nasdaq: Meta) actions rose more than 4% after the quarterly results and forecasts exceed consensus. The Facebook and Instagram parent company anticipated capital expenses for the entire 2025 in the range of 64,000-72,000 million dollars, increased since its previous forecast of 60,000-65,000 million dollars.
Microsoft Corporation actions (Nasdaq: MSFT) rose more than 7% after the revenues of the first quarter of the software giant increased by 13%. It also predicted a growth of cloud computing income from 34% to 35% for the fourth fiscal quarter.
On the other hand, the actions of McDonald’s (NYSE: MCD) fell more than 1% after reporting an unexpected fall in global sales of the first quarter, while Eli Lilly (Nyse: Llyse: LLY) fell down 11% due to the weak sales of their medicine to lose weight Zepbound.
Related news :